Statistics
Publications
14
Citations
814
H-Index
13
Active since
2007
Cong Chen is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in oncology, clinical trial phases, and clinical trials.
Publications per year
2007–2023
14
14
A 2-in-1 adaptive phase 2/3 design for expedited oncology drug development
Cong Chen, Keaven M. Anderson, Devan V. Mehrotra et al. · Contemporary Clinical Trials · 2017 · 61 citations
Medicine, Oncology, Pharmacology +11
In Vitro and in Vivo Antitumor Evaluation of Berbamine for Lung Cancer Treatment
Zhibo Hou, Kaijin Lu, Xiaoli Wu et al. · Asian Pacific Journal of Cancer Prevention · 2014 · 40 citations · Full text
Medicine, Oncology, Pharmacology +11
1–5 of 14